0
views
0
recommends
+1 Recommend
0 collections
    0
    shares
      • Record: found
      • Abstract: found
      • Article: found
      Is Open Access

      Plasma cell myeloma in a 9‐year‐old male: Case report and literature review

      case-report

      Read this article at

      Bookmark
          There is no author summary for this article yet. Authors can add summaries to their articles on ScienceOpen to make them more accessible to a non-specialist audience.

          Abstract

          Key Clinical Message

          Plasma cell myeloma is a rare entity in the pediatric population. The peak incidence is in the seventh decade, with less than 2% of cases occurring in patients under the age of 40. It is worth noting that any destructive bony lesion in a child should be investigated.

          Abstract

          Plasma cell myeloma (multiple myeloma) is the most common form of plasma cell neoplasm. It is a rare entity in young patients. The peak incidence is in the seventh decade, with less than 2% of cases occurring in patients under the age of 40. A male patient aged 9 years old with a progressive pain in lower back for about 1 month, aggravated by bending, associated with inability to stand upright, no any history of trauma. He complained about left pin‐point chest pain, no any history of febrile illness. MRI showed a mass lesion of the L3 vertebra; CT scan revealed osteolytic lesions in the left T12, S2‐sacral region, and left calvarium. Histology report of L3 lesion revealed cells with an eccentric nucleus, prominent Golgi apparatus and Flow cytometry revealed cells stained positive for CD 138 and CD56 and negative for CD45 expression. In situ hybridization identified k‐light chain band restriction. Bone marrow evaluation was normal. A small serum monoclonal immunoglobin A spike of k‐light chain type was noted. Other tests like complete blood count, lactate dehydrogenase levels, renal functional tests, and B2‐microglobulin were normal. A diagnosis of plasma cell myeloma was made and the patient was started on emergent radiation to L3 lesion due to progressive neurological symptoms followed systemic therapy which resulted int reduction of L3 lesion. Plasma cell myeloma is extremely rare form of liquid tumor in the pediatric population, and it is important for any destructive bony lesion in a child to have appropriate work up.

          Related collections

          Most cited references10

          • Record: found
          • Abstract: found
          • Article: not found

          Long-term trends in cancer mortality in the United States, 1930-1998.

          Progress against cancer can be examined by analyzing long-term trends in cancer incidence and mortality. The recent directive from the U.S. Department of Health and Human Services to adopt the 2000 U.S. standard population for the age adjustment of death rates prompted the American Cancer Society to update historical cancer mortality statistics using the new standard. Mortality data were abstracted by race, gender, year, and age at death for 1930 through 1959 from annual volumes of Vital Statistics of the United States. For 1960 through 1998, these data were obtained from data tapes provided by the National Center for Health Statistics. Two U.S. standard million populations (1970 and 2000) were used to calculate age-adjusted rates. Average annual percent change was estimated for each decade by site, gender, and age, and the statistical significance of the change was assessed at p < 0.05. After long-term increases or mostly level trends that date from the 1930s for some sites, death rates for cancers of the lung (in males), prostate, female breast, colon-rectum, pancreas, leukemia, and ovary were decreasing in the 1990s. Liver cancer death rates were increasing in the 1990s. Throughout the study period, death rates for female lung cancer increased, while death rates for stomach and uterine cancers declined. The trends of decreasing cancer death rates for the leading cancer sites in the 1990s are encouraging. However, surveillance researchers must continue to monitor these declines to assess whether the progress seen in this decade persists. Efforts also must be made to study the sites with increasing trends and identify potential underlying causes.
            Bookmark
            • Record: found
            • Abstract: found
            • Article: found
            Is Open Access

            Solitary plasmacytoma: population-based analysis of survival trends and effect of various treatment modalities in the USA

            Background Solitary plasmacytoma (SP) is a localized neoplastic plasma cell disorder with an annual incidence of less than 450 cases. Given the rarity of this disorder, it is difficult to conduct large-scale population studies. Consequently, very limited information on the disorder is available, making it difficult to estimate the incidence and survival rates. Furthermore, limited information is available on the efficacy of various treatment modalities in relation to primary tumor sites. Methods The data for this retrospective study were drawn from the Surveillance, Epidemiology and End Results (SEER) database, which comprises 18 registries; patient demographics, treatment modalities and survival rates were obtained for those diagnosed with SP from 1998 to 2007. Various prognostic factors were analyzed via Kaplan-Meier analysis and log-rank test, with 5-year relative survival rate defined as the primary outcome of interest. Cox regression analysis was employed in the multivariate analysis. Results The SEER search from 1998 to 2007 yielded records for 1691 SP patients. The median age at diagnosis was 63 years. The patient cohort was 62.4% male, 37.6% female, 80% Caucasian, 14.6% African American and 5.4% other races. Additionally, 57.8% had osseous plasmacytoma, and 31.9% had extraosseous involvement. Unspecified plasmacytoma was noted in 10.2% of patients. The most common treatment modalities were radiotherapy (RT) (48.8%), followed by combination surgery with RT (21.2%) and surgery alone (11.6%). Univariate analysis of prognostic factors revealed that the survival outcomes were better for younger male patients who received RT with surgery (p  60 years was associated with a lower 5-year survival in patients who progressed to MM compared to those who were diagnosed initially with MM (15.1 vs 16.6%). Finally, those who received RT and progressed to MM still had a higher chance of survival than those who were diagnosed with MM initially and treated with RT/surgery (21.8% vs 15.9%, p < 0.05). Conclusions A review of the pertinent literature indicates that we provided the most comprehensive population-based analysis of SP to date. Moreover, our study contributes to the establishment of the optimal SP treatment modality, as RT is the favored option in frontline settings. Consensus is currently lacking regarding the benefits of combined treatment including surgery. Thus, the findings reported here elucidate the role of primary treatment modalities while also demonstrating the quantifiable benefits of combining RT with surgery in relation to different primary tumor sites. While our results are promising, they should be confirmed through further large-scale randomized studies. Electronic supplementary material The online version of this article (doi:10.1186/s12885-016-3015-5) contains supplementary material, which is available to authorized users.
              Bookmark
              • Record: found
              • Abstract: found
              • Article: not found

              Role of MRI for the diagnosis and prognosis of multiple myeloma.

              For the correct staging of patients with multiple myeloma sensitive detection is mandatory in order to estimate prognosis and to decide for adequate therapy. Magnetic resonance imaging (MRI) is superior to radiography for both, focal and diffuse involvement. Five different infiltration patterns can be differentiated: (1) normal appearance of bone marrow despite minor microscopic plasma cell infiltration, (2) focal involvement, (3) homogeneous diffuse infiltration, (4) combined diffuse and focal infiltration, (5) "salt-and-pepper"-pattern with inhomogeneous bone marrow with interposition of fat islands. For the fast and complete assessment of all patterns a combination of a T1-weighted spin echo sequence and a fat suppression technique should be employed. The focal involvement is clearly demonstrated as areas of high signal intensity on, e.g. STIR images. Diffuse involvement is best detected on unenhanced T1-weighted SE sequences and it manifests as homogeneous signal reduction. It can be quantified objectively by calculation of the percentage of signal intensity increase after contrast material injection. With parallel imaging and special coil devices, such as total imaging matrix (Siemens systems, Avanto) a "screening" of the whole red bone marrow as for myeloma infiltration is possible within a reasonable time. Patients without bone marrow infiltration have a significantly longer survival than patients with bone marrow infiltration in MRI at the time of diagnosis. However, even in stage I disease (Durie and Salmon) and negative X-ray films bone marrow infiltration in MRI may be detected in 29-50% of patients. Those patients typically show an earlier disease progression. Recently, MRI has been implemented in the clinical staging of patients with multiple myeloma. MRI may also monitor response to therapy. Signs of good response in cases with focal involvement are: reduction of signal intensity on T2-weighted spin echo images, lack or rim-like enhancement after contrast material injection or even a normalisation of bone marrow signal. In case of diffuse involvement a partly patchy reconversion to fatty marrow can be seen.
                Bookmark

                Author and article information

                Contributors
                kato.ronald89@gmail.com
                Journal
                Clin Case Rep
                Clin Case Rep
                10.1002/(ISSN)2050-0904
                CCR3
                Clinical Case Reports
                John Wiley and Sons Inc. (Hoboken )
                2050-0904
                20 April 2024
                April 2024
                : 12
                : 4 ( doiID: 10.1002/ccr3.v12.4 )
                : e8801
                Affiliations
                [ 1 ] Department of Emergency Medicine Savannah Hospital Nairobi Kenya
                [ 2 ] Department of Oncology Uganda Cancer Institute Kampala Uganda
                [ 3 ] Department of Internal Medicine King David Hospital Nairobi Kenya
                Author notes
                [*] [* ] Correspondence

                Kato Ronald, Division of Internal Medicine, The Savannah Hospital, Nairobi, Kenya.

                Email: kato.ronald89@ 123456gmail.com

                Author information
                https://orcid.org/0000-0002-9532-9807
                Article
                CCR38801 CCR3-2023-12-2714.R2
                10.1002/ccr3.8801
                11031740
                38645602
                4117b463-6296-456b-8655-a0f099ff2561
                © 2024 The Authors. Clinical Case Reports published by John Wiley & Sons Ltd.

                This is an open access article under the terms of the http://creativecommons.org/licenses/by/4.0/ License, which permits use, distribution and reproduction in any medium, provided the original work is properly cited.

                History
                : 20 February 2024
                : 01 December 2023
                : 28 March 2024
                Page count
                Figures: 2, Tables: 0, Pages: 5, Words: 2000
                Categories
                Oncology
                Case Report
                Case Report
                Custom metadata
                2.0
                April 2024
                Converter:WILEY_ML3GV2_TO_JATSPMC version:6.4.0 mode:remove_FC converted:20.04.2024

                biopsy,histology,immunoglobulin,lesion,plasma cell myeloma
                biopsy, histology, immunoglobulin, lesion, plasma cell myeloma

                Comments

                Comment on this article